Stay updated with breaking news from Authorized Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
European Commission exercise part of its option for over 200 million additional doses to be delivered in 2022 These doses are in addition to the 450 million doses already planned for delivery
First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that
/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab and etesevimab administered...
/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab and etesevimab administered...
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an additional purchase by the U.S. government for bamlanivimab with etesevimab for...